Description
Quest Diagnostics: Enhanced Offerings In Cardiometabolic Testing & Autoimmune Disorders Catalyzing Growth!
Quest Diagnostics Inc. reported strong financial performance for the fourth quarter and full year of 2024, driven primarily by revenue growth from acquisitions and robust organic growth. Revenue for the fourth quarter increased by 14.5% to $2.62 billion, with organic revenue growth accounting for nearly 5%. This growth was supported by the completion of eight acquisitions within the year, including LifeLabs in Canada and several hospital outreach lab businesses in the U.S. These acquisitions bolstered the company’s market position, particularly within the physician and hospital channels, and expanded its geographic reach.
Our Report Structure:
⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures
Want unlimited access to our reports? Purchase our $99 annual subscription!
